» Articles » PMID: 4681895

Ornithine Transcarbamylase Deficiency: a Cause of Lethal Neonatal Hyperammonemia in Males

Overview
Journal N Engl J Med
Specialty General Medicine
Date 1973 Jan 4
PMID 4681895
Citations 24
Authors
Affiliations
Soon will be listed here.
Citing Articles

Long-term correction of ornithine transcarbamylase deficiency in Spf-Ash mice with a translationally optimized AAV vector.

De Sabbata G, Boisgerault F, Guarnaccia C, Iaconcig A, Bortolussi G, Collaud F Mol Ther Methods Clin Dev. 2021; 20:169-180.

PMID: 33473356 PMC: 7786024. DOI: 10.1016/j.omtm.2020.11.005.


Rapid resolution of hyperammonemia in neonates using extracorporeal membrane oxygenation as a platform to drive hemodialysis.

Robinson J, Conroy P, Hardison D, Hamid R, Grubb P, Pietsch J J Perinatol. 2018; 38(6):665-671.

PMID: 29467521 PMC: 6030490. DOI: 10.1038/s41372-018-0084-0.


Short-term survival of hyperammonemic neonates treated with dialysis.

Picca S, Dionisi-Vici C, Bartuli A, De Palo T, Papadia F, Montini G Pediatr Nephrol. 2014; 30(5):839-47.

PMID: 25185886 DOI: 10.1007/s00467-014-2945-x.


1H MRS identifies symptomatic and asymptomatic subjects with partial ornithine transcarbamylase deficiency.

Gropman A, Fricke S, Seltzer R, Hailu A, Adeyemo A, Sawyer A Mol Genet Metab. 2008; 95(1-2):21-30.

PMID: 18662894 PMC: 3724938. DOI: 10.1016/j.ymgme.2008.06.003.


X-linked dominant inherited diseases with lethality in hemizygous males.

Kantner G Hum Genet. 1983; 64(1):1-23.

PMID: 6873941 DOI: 10.1007/BF00289472.